Cargando…

Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report

BACKGROUND: Sheng-Xue-Xiao-Ban Capsule (SXXBC), as a classic Chinese traditional medicine comprised of natural indigo, cortex moutan, forsythia, herba agrimoniae, and licorice, exhibits a heat-clearing and detoxicating function, hemostasis, and stasis dissipation, which is widely applied to treat id...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Sisi, Shi, Quan, Zheng, Yanfeng, Zhuang, Yihan, Lin, Yiting, Huang, Zeyu, Yu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577723/
https://www.ncbi.nlm.nih.gov/pubmed/36267749
http://dx.doi.org/10.21037/atm-22-3951
_version_ 1784811821551583232
author Zhou, Sisi
Shi, Quan
Zheng, Yanfeng
Zhuang, Yihan
Lin, Yiting
Huang, Zeyu
Yu, Jing
author_facet Zhou, Sisi
Shi, Quan
Zheng, Yanfeng
Zhuang, Yihan
Lin, Yiting
Huang, Zeyu
Yu, Jing
author_sort Zhou, Sisi
collection PubMed
description BACKGROUND: Sheng-Xue-Xiao-Ban Capsule (SXXBC), as a classic Chinese traditional medicine comprised of natural indigo, cortex moutan, forsythia, herba agrimoniae, and licorice, exhibits a heat-clearing and detoxicating function, hemostasis, and stasis dissipation, which is widely applied to treat idiopathic thrombocytopenic purpura (ITP). However, report on ischemic colitis and pulmonary embolism induced by SXXBC therapy is never disclosed. We report the case of an ITP patient who received SXXBC for ascending platelets that then induced ischemic colitis and pulmonary embolism. CASE DESCRIPTION: A 74-year-old female patient was admitted in June 2021 due to “bleeding in stool for 1 day,” she was then re-admitted in July 2021 due to “repeated bleeding in stool for 2 days”. Abdominal computed tomography (CT), colonoscopy, and a pathological examination suggested ischemic colitis according to the American College of Gastroenterology (ACG) clinical guidelines. Pulmonary artery CT angiography suggested pulmonary embolism reflected by multiple filling defects, and the patient presented with shortness of breath. It was noted that the patient had started taken SXXBC for ascending platelets 2 months before the onset of hematochezia. After the diagnosis of hematochezia was made, the patient received phenethylamine and carbazochrome for hemostasis, mesalazine enteric-coated tablets for anti-inflammation, and SXXBC was stopped. The hematochezia then ceased, and the ischemic colitis was attenuated. Afterwards, low-molecular-weight heparin was administered, followed by a 3-week treatment of rivaroxaban anticoagulant, which was taken orally after discharge. The pulmonary embolism was then obviously ameliorated. After excluding other causes, the patient was diagnosed with SXXBC–induced ischemic colitis complicated by pulmonary embolism. After conducting research, we came to the view that natural indigo, which is the main component of SXXBC, contributed to the patient’s illness. CONCLUSIONS: Ischemic colitis complicated with pulmonary embolism are rare; however, close attention such as regular abdominal CT test needs to be paid and preventive steps such as anti-coagulant treatment could to be taken (if symptoms occur) when treating patients with SXXBC.
format Online
Article
Text
id pubmed-9577723
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-95777232022-10-19 Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report Zhou, Sisi Shi, Quan Zheng, Yanfeng Zhuang, Yihan Lin, Yiting Huang, Zeyu Yu, Jing Ann Transl Med Case Report BACKGROUND: Sheng-Xue-Xiao-Ban Capsule (SXXBC), as a classic Chinese traditional medicine comprised of natural indigo, cortex moutan, forsythia, herba agrimoniae, and licorice, exhibits a heat-clearing and detoxicating function, hemostasis, and stasis dissipation, which is widely applied to treat idiopathic thrombocytopenic purpura (ITP). However, report on ischemic colitis and pulmonary embolism induced by SXXBC therapy is never disclosed. We report the case of an ITP patient who received SXXBC for ascending platelets that then induced ischemic colitis and pulmonary embolism. CASE DESCRIPTION: A 74-year-old female patient was admitted in June 2021 due to “bleeding in stool for 1 day,” she was then re-admitted in July 2021 due to “repeated bleeding in stool for 2 days”. Abdominal computed tomography (CT), colonoscopy, and a pathological examination suggested ischemic colitis according to the American College of Gastroenterology (ACG) clinical guidelines. Pulmonary artery CT angiography suggested pulmonary embolism reflected by multiple filling defects, and the patient presented with shortness of breath. It was noted that the patient had started taken SXXBC for ascending platelets 2 months before the onset of hematochezia. After the diagnosis of hematochezia was made, the patient received phenethylamine and carbazochrome for hemostasis, mesalazine enteric-coated tablets for anti-inflammation, and SXXBC was stopped. The hematochezia then ceased, and the ischemic colitis was attenuated. Afterwards, low-molecular-weight heparin was administered, followed by a 3-week treatment of rivaroxaban anticoagulant, which was taken orally after discharge. The pulmonary embolism was then obviously ameliorated. After excluding other causes, the patient was diagnosed with SXXBC–induced ischemic colitis complicated by pulmonary embolism. After conducting research, we came to the view that natural indigo, which is the main component of SXXBC, contributed to the patient’s illness. CONCLUSIONS: Ischemic colitis complicated with pulmonary embolism are rare; however, close attention such as regular abdominal CT test needs to be paid and preventive steps such as anti-coagulant treatment could to be taken (if symptoms occur) when treating patients with SXXBC. AME Publishing Company 2022-09 /pmc/articles/PMC9577723/ /pubmed/36267749 http://dx.doi.org/10.21037/atm-22-3951 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Case Report
Zhou, Sisi
Shi, Quan
Zheng, Yanfeng
Zhuang, Yihan
Lin, Yiting
Huang, Zeyu
Yu, Jing
Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report
title Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report
title_full Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report
title_fullStr Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report
title_full_unstemmed Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report
title_short Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report
title_sort sheng-xue-xiao-ban capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577723/
https://www.ncbi.nlm.nih.gov/pubmed/36267749
http://dx.doi.org/10.21037/atm-22-3951
work_keys_str_mv AT zhousisi shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport
AT shiquan shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport
AT zhengyanfeng shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport
AT zhuangyihan shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport
AT linyiting shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport
AT huangzeyu shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport
AT yujing shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport